Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution
Review of hundreds of internal FDA documents obtained under FOIA finds FDA generally followed cautious and evidence-based ...
Keshia M. Pollack Porter, PhD ’06, MPH, an internationally recognized health policy scholar, trusted leader, and unwavering advocate for public health, became the 12th dean of the Bloomberg School on ...
Virtual chats and info sessions offer interested students an informal opportunity to learn about life at the Bloomberg School. Chats are held select Thursdays from 12 p.m. to 1 p.m. EST, or you can ...
- None - I am a clinical professional seeking to access this training for myself and/or team at the organization listed above. I am a non-clinical professional seeking to access this training for ...
At the end of March, the KP.2 variant was causing about 4% of infections in the U.S., according to the CDC, while its parental strain, JN.1, was causing over 50% of infections at that time. As of ...
As with any drug or medical product, when we decide to take a vaccine, we want to feel confident that its benefits outweigh any possible risks. Scientists and public health researchers take those ...
The U.S. has one of the lowest tuberculosis incidence rates in the world. So when there are outbreaks of this bacterial infection, like the one reported last month in Kansas, they get our attention.
Since the 1970s, methadone has been used to treat opioid use disorder (OUD) with great success—reducing the likelihood of dying from an opioid overdose by 50% or more. Yet for patients and prescribers ...
The U.S. is experiencing its sharpest decline in life expectancy in more than a century—since the eras of World War I and the Great Influenza. What happened? Until 2014 life expectancy at birth in the ...
In 1971, the FDA approved the measles-mumps-rubella (MMR) vaccine, which combined three vaccines that had been approved previously—in 1963, 1967, and 1969, respectively. The vaccine has proven safe ...
In the early days of the pandemic, clinicians began to treat COVID-19 patients with the plasma of people who have recovered from COVID-19. The idea was that protective antibodies in the plasma would ...
* The data presented in the maps are compiled from official sources, including state and county health departments and additional county-level news releases or news articles, and represent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results